• Enzalutamide prolongs upfront survival in hormone-sensitive metastatic prostate cancer

    The non-steroidal antiandrogen ensalutamide plus standard therapy increased the 3-year survival rate in men with mHSPC to 80% compared to 72% achieved with other non-steroidal antiandrogens. This was confirmed by an interim analysis of the phase III ENZAMET study.

  • Which first-line therapy is appropriate for BRAF-mutated metastatic melanoma?

    In about 50% of metastasized melanomas, a BRAF mutation is found, in these cases, targeted therapy can be applied. But immunotherapeutics have also revolutionized melanoma treatment in the last ten years.

  • Breast cancer: A joint ribociclib-endocrine therapy prolong overall survival

    For the first time, a biomarker-based therapy prolonged overall survival in premenopausal women with breast cancer. In the MONALEESA 7 Phase III study, a joint Ribociclib/endocrine therapy reduced death risk by 29%.

  • Squamous cell carcinoma in the anal region: prevention and therapy

    Anal carcinoma is closely associated with infection by human papillomaviruses. An HPV vaccination, therefore, offers a good possibility for prevention.

  • Social media and the life quality of oncologists

    There are many reasons for physicians to become involved in social media, and various studies have now also proven the benefits. Nonetheless, risks must also be taken into account, as we learned at ASCO 2019.

  • Older frail patients with gastroesophageal adenocarcinoma benefit from low-dose chemotherapy

    The lowest dose of oxaliplatin/capecitabine tested was as effective in elderly and frail patients with advanced gastroesophageal carcinoma as the highest dose investigated.

  • CAR-T Cell Therapy: The other side of the coin

    CAR-T cell therapy is highly controversial in research. The two most important side effects, cytokine release syndrome, and neurotoxicities were presented and discussed in a symposium.

  • Latest news on PARP and other DNA-damage response targets

    Cancer-specific DNA repair defects are common in malignant tissue, but they provide an opportunity for therapeutic attack.

  • Olaparib prolongs progression-free survival in BRCA germline mutated pancreatic cancer

    For the first time, a biomarker-based therapeutic approach in pancreatic cancer has been able to prolong progression-free survival (PFS).

  • Parents as diagnostic assistants: App help us!

    With a homemade paper funnel and a mobile phone app, parents are able to detect fluid accumulation in the middle ear of their children.

  • More young people are being diagnosed with colorectal cancer

    A retrospective study showed a trend towards more colorectal cancer in younger patients across Europe over the past 25 years. Do guidelines for early detection need to be rewritten?

  • New guideline recommendations for addressing gynecomastia

    The European Academy of Andrology (EAA) has issued a new guideline with 15 recommendations for managing these clinical cases.

  • NASA studied identical twin brothers: one on Earth, one in outer space

    The results of the "Twins Study" conducted by NASA to study the impact of space flight on human health, were published in the journal Science. Two identical twins, Mark and Scott, were the subject of this study, one of whom spent over 300 days inside the International Space Station.

  • Ultrasound used to treat diabetes

    A recent study on mice concludes that targeted ultrasound could be an effective, noninvasive and drug-free way to increase insulin levels in people with type 2 diabetes.

  • Osteoporosis too often goes undetected

    For osteoporosis, there is still a lot of catching up needed throughout Europe: some 85% of women with osteoporosis-related bone fractures do not receive adequate treatment to prevent the recurrence of such fractures.

  • Prostate carcinoma has an affinity to sugar

    A recent retrospective observational study in diabetic men with prostate cancer suggests that poor glycemic control before radical prostatectomy increases the risk of later progression, including metastasis.

  • First figures on PrEP and STIs study in Germany

    HIV-negative men who have sex with men (MSM), who use PrEP, are significantly more likely to have other sexually transmitted diseases.

  • New antibody prevents HIV multiplication

    Researchers have tested another antibody against HIV that suppressed the further proliferation of the virus in infected individuals.

  • Pertussis vaccine: A 5-year protection timeframe

    Acellular vaccines against Bordetella pertussis protect about 75% of vaccinated children between the ages of five and nine years. Approximately 65% of these children are vaccinated for five years. However, it is not possible to eradicate the disease.

  • Antimycotic resistance in invasive fungal infections

    A current study shows that the pathogen spectrum has changed in recent years and that more antifungal resistance is occurring.

  • 74 |
  • 75 |
  • 76 |
  • 77 |
  • 78 |
  • 79 |
  • 80 |
  • 81 |
  • 82 |
  • 83 |
  • 84 |